| ||||||||||||||
|
|
|||||||||||||
Received from the Departments of Anesthesia and Pathology, University of California, San Francisco; and the Department of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, Ontario, Canada. Dr. Eger is a consultant to Anaquest, the manufacturer of enflurane.
Abstract
We evaluated 88 cases of hepatic injury that followed, and were attributed to, enflurane anesthesia. In 30 of the cases, data were insufficient to assess the role of enflurane vs other variables as causal factors. In 43 ("unlikely") patients, factors known to produce hepatic injury were clearly present; in the remaining 15 ("possible"), such factors were not evident. No consistent pathologic change was found in liver specimens from either the unlikely or the possible group of cases. A syndrome suggested to be associated with enflurane-induced hepatic injury was present in both groups and did not differ between groups. We conclude that the data do not demonstrate a causal relationship between enflurane anesthesia and subsequent liver injury and that if severe injury is caused by enflurane anesthesia, it is an extremely rare event.
Key Words: ANESTHETICS VOLATILE-enflurane LIVER-hepatotoxicity
This article has been cited by other articles:
![]() |
T. Nishiyama, T. Fujimoto, and K. Hanaoka A Comparison of Liver Function After Hepatectomy in Cirrhotic Patients Between Sevoflurane and Isoflurane in Anesthesia with Nitrous Oxide and Epidural Block Anesth. Analg., April 1, 2004; 98(4): 990 - 993. [Abstract] [Full Text] [PDF] |
||||
|